Clinical Trials Sponsored by Vicore Pharma AB

Total 203 results

Vifor Pharma

Terminated

Ferric Carboxymaltose for Treatment of Anaemia of Cancer in Subjects With Multiple Myeloma Receiving Chemotherapy (AOC-MM)

Iron-Deficiency Anemia

France, Greece
Vifor Pharma

Completed

A Drug-Drug Interaction Study of Omeprazole and PA21

Healthy

United States
Vifor Pharma

Completed

Effect of Ferric Carboxymaltose on Exercise Capacity in Patients With Iron Deficiency and Chronic Heart Failure (EFFECT-HF)

Chronic Heart Failure | Iron Deficiency

Netherlands
Vifor Pharma

Completed

Study of Phosphate Levels in Patients With Chronic Kidney Disease (PA21)

Chronic Kidney Disease

United States, Switzerland, Romania, Croatia, Bulgaria, Germany, Czech Republic, Poland, Russian Federation
Vifor Pharma

Completed

Broncho-Vaxom (OM 85 BV) in Children Suffering From Atopic Dermatitis

Atopic Dermatitis
Vifor Pharma

Completed

Ferric Carboxymaltose in Subjects With Functional Iron Deficiency Undergoing Chemotherapy (FID-CHEMO)

Iron-Deficiency Anemia

Germany, Sweden
Vifor Pharma

Completed

A Drug-Drug Interaction Study of Losartan and PA21

Drug Interaction Potentiation

United States
Vifor Pharma

Completed

A Drug-Drug Interaction Study of Warfarin and PA21

Drug Interaction Potentiation

United States
Vifor Pharma

Completed

A Drug-Drug Interaction Study of Digoxin and PA21

Drug Interaction Potentiation

United States
Vifor Pharma

Completed

A Drug-Drug Interaction Study of Furosemide and PA21

Healthy

United States
Vifor Pharma

Terminated

Ferinject® in Patient With Thrombocytosis Secondary to Inflammatory Bowel Disease (IBD)

Thrombocytosis | Iron-Deficiency Anemia

Austria
gicare Pharma Inc.

Completed

A Clinical Phase I Study on GIC-1001 in Healthy Volunteers

Colonic Diseases

Canada
PepTonic Medical AB
Pharma Consulting Group AB

Completed

Dose-relationship of Vaginally Administrated Oxytocin in Postmenopausal Women (OXYPEP002)

Vaginal Atrophy

Sweden
Cinclus Pharma Holding AB

Completed

Effect of Clarithromycin on PK of Linaprazan, Linaprazan on PK of Clarithromycin and Linaprazan on PK of Midazolam

Pharmacokinetics | Safety Issues | Tolerability | Drug Interaction

Sweden
Gesynta Pharma AB
Ergomed

Completed

A Study to Investigate Safety of GS-248 and Efficacy on Raynauds' Phenomenon in Systemic Sclerosis

Systemic Sclerosis

United Kingdom, Poland, Belgium, Netherlands
2A Pharma AB
Celerion

Completed

A Study of Safety, Tolerability and Immunogenicity of HPV-L2 Vaccine in Healthy Adult Male and Female Subjects

Papillomavirus Infections

United Kingdom
BioGaia Pharma AB
BioFortis

Recruiting

Safety and Preliminary Efficacy of BGP345A in Constipation Due to Opioid-based Medications (OIC1)

Opioid-Induced Constipation

France
Cinclus Pharma Holding AB

Active, not recruiting

Investigate Linaprazan Glurate/Linaprazan in Healthy Subjects

GERD

Slovenia
Vifor (International) Inc.

Active, not recruiting

Cardiovascular and Renal Treatment in Heart Failure Patients With Hyperkalaemia or at High Risk of Hyperkalaemia (CARE-HK)

Heart Failure | Hyperkalemia

Spain, United States, United Kingdom, Italy, Switzerland, Belgium, Austria
Vifor (International) Inc.

Active, not recruiting

Cross-sectional Study to Assess Prevalence and Burden of CKD-associated Pruritus in Haemodialysis Patients (ReliefCensus)

Chronic Kidney Disease-associated Pruritus

Germany, Italy, Portugal, Spain, Sweden, Switzerland, United Kingdom
Vifor (International) Inc.

Withdrawn

Cross-sectional Study to Assess Prevalence and Burden of CKD-associated Pruritus in Hemodialysis Patients (CKD)

Chronic Kidney Disease-associated Pruritus
Vifor (International) Inc.

Completed

Bioavailability Study Comparing 2 Vamifeport Oral Formulations in Fasted Versus Fed State in Healthy Subjects

Healthy

United Kingdom
Pharmiva AB
Key2Compliance; Replior AB

Completed

A User Study With Vernivia® for Bacterial Vaginosis. (USV01)

Bacterial Vaginoses

Sweden
Vifor Pharma, Inc.
Syneos Health, LLC

Completed

Patiromer for the Management of Hyperkalemia in Subjects Receiving RAASi Medications for the Treatment of Heart Failure (DIAMOND) (DIAMOND)

Hyperkalemia

United States, Argentina, Belgium, Brazil, Bulgaria, Canada, Czechia, France, Georgia, Germany, Hungary, Israel, Italy, Mexico, Netherlands, Poland, Russian Federation, Serbia, Spain, Ukraine, United Kingdom
Vifor Pharma
Parexel

Completed

Maintenance Treatment of Iron Deficiency in IBD Patients (FER-IBD-MAIN)

Iron Deficiency | Inflammatory Bowel Disease

Russian Federation
AiCure
Montefiore Medical Center; Orexo AB

Completed

Using Artificial Intelligence To Monitor Medication Adherence in Opioid Replacement Therapy

Addiction | Opioid Dependence | Opiate Addiction | Medication Non-adherence

United States
Vifor (International) Inc.

Active, not recruiting

RAYALDEE Non Interventional Study (NIS) on Effectiveness in ND-CKD SHPT Patients (PORTRAY)

Chronic Kidney Disease

Germany
Empros Pharma AB
CTC Clinical Trial Consultants AB

Recruiting

A Phase 1 Study to Evaluate EMP22 PD and EMP16 PK Versus Xenical® in Healthy Volunteers

Overweight or Obesity

Sweden
Gesynta Pharma AB
CTC Clinical Trial Consultants AB

Completed

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GS-248

Healthy

Sweden
Empros Pharma AB
CTC Clinical Trial Consultants AB

Active, not recruiting

Study Exploring the Supportive Effect of Acarbose in Weight Management

Overweight or Obesity

Sweden
Viscogel AB
Karolinska Institutet; Pharma Consulting Group AB

Completed

Single-center Study Evaluating the Safety and Efficacy of Viscogel® as Adjuvant in Act-HIB® Vaccine (VSG-2011-101)

Healthy

Sweden
Empros Pharma AB
CTC Clinical Trial Consultants AB

Completed

A Proof of Concept Trial in Overweight and Obese Patients, Investigating Effect of EMP16-02 on Body Weight (Primary)

Overweight or Obesity

Sweden
Kringle Pharma Europe AB
Kringle Pharma, Inc.

Unknown

Phase I/II Dose Ranging CHRONSEAL® Study in Venous Leg Ulcers

Chronic Venous Leg Ulcers

Norway, Sweden
gicare Pharma Inc.
Algorithme Pharma Inc

Completed

Study on Analgesia of GIC-1001 & GIC-1002 on Visceral Pain, Rectal Sensory Threshold Using the Barostat Method

Pain | Cancer | Colonic Disease

Canada
Lokon Pharma AB
Uppsala University

Active, not recruiting

Trial Investigating an Immunostimulatory Oncolytic Adenovirus for Cancer

Colorectal Cancer | Pancreatic Adenocarcinoma | Ovarian Cancer | Biliary Carcinoma

Sweden
ChronTech Pharma AB
Inovio Pharmaceuticals

Unknown

CHRONVAC-C Study Followed by Standard of Care in Chronic Hepatitis C Virus (HCV) Subjects

Chronic Hepatitis C

Sweden
Vifor (International) Inc.
Fortrea

Completed

Study to Assess Efficacy and Safety of VIT-2763 (Vamifeport) in Subjects With Sickle Cell Disease (ViSionSerenity)

Sickle Cell Disease

United States, France, Greece, Lebanon, United Kingdom
Duke University
Vifor Pharma

Completed

Patiromer Efficacy to Reduce Episodic Hyperkalemia in End Stage Renal Disease Patients

End Stage Renal Disease | Hyperkalemia

United States
Relypsa, Inc.

Completed

A Two-Part, Single-Blind, Phase 3 Study Evaluating the Efficacy and Safety of Patiromer for the Treatment of Hyperkalemia (OPAL) (OPAL)

Chronic Kidney Disease (CKD) | Hyperkalemia (HK)

United States, Croatia, Czechia, Denmark, Georgia, Hungary, Italy, Serbia, Slovenia, Ukraine
Relypsa, Inc.

Completed

Spironolactone With Patiromer in the Treatment of Resistant Hypertension in Chronic Kidney Disease (AMBER)

Hyperkalemia | Resistant Hypertension

United States, Bulgaria, Croatia, Georgia, Germany, Hungary, South Africa, Ukraine, United Kingdom
Göteborg University
Vifor Pharma

Completed

Omega 3/6 Fatty Acids for Reading in Children

Reading Ability
Relypsa, Inc.

Completed

Patiromer in the Treatment of Hyperkalemia in Patients With Hypertension and Diabetic Nephropathy (AMETHYST-DN) (AMETHYST-DN)

Hypertension | Chronic Kidney Disease | Hyperkalemia

Croatia, Georgia, Hungary, Serbia, Slovenia
Relypsa, Inc.

Terminated

An Open-Label, Multiple Dose Study to Evaluate the Pharmacology, Safety, and Tolerability of Patiromer in Participants on Hemodialysis

Hyperkalemia

United States
Relypsa, Inc.

Completed

Patiromer With or Without Food for the Treatment of Hyperkalemia (TOURMALINE)

Hyperkalemia

United States
Hospital Aleman
Vifor Pharma

Completed

Switch From Oral Iron to Intravenous Ferric Carboxymaltose in Non-dialysis Chronic Kidney Disease (CKD)

Iron Deficiency | Anaemia

Argentina
Vifor Pharma
SGS S.A.

Completed

Ferric Carboxymaltose Treatment to Improve Fatigue Symptoms in Iron-deficient Non-anaemic Women of Child Bearing Age (Prefer)

Iron Deficiency

Austria
Göteborg University
Vifor Pharma

Completed

Omega-3/Omega-6 Fatty Acids for Attention-Deficit/Hyperactivity Disorder (ADHD): A Trial in Children and Adolescents

ADHD | Reading/Writing Disorder
Relypsa, Inc.

Completed

Evaluation of Patiromer Titration in Heart Failure Patients With Chronic Kidney Disease

Heart Failure

Georgia, Slovenia
Mahidol University
Vifor Pharma

Completed

Intravenous Versus Oral Iron in Late Pregnancy: Results of Treatment (EIVF)

Anemia | Pregnancy Complications

Thailand
Pharmiva AB
CPS Research; Scandinavian Development Services AB; Key2Compliance AB

Active, not recruiting

Efficacy and Safety of D005 Vaginal Mousse on Bacterial Vaginosis

Bacterial Vaginosis | Vaginal | Microbiology

Sweden, United Kingdom

Clinical Trials Sponsored by Vicore Pharma AB

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mauritius

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations